SMAD7 rs4939827 variant contributes to colorectal cancer risk in Chinese population

Chunze Zhang; Xichuan Li; Wenzheng Fu; Yijia Wang; Tao Wang; Wenhong Wang; Shuo Chen; Hai Qin; Xipeng Zhang

doi:10.18632/oncotarget.17065

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

SMAD7 rs4939827 variant contributes to colorectal cancer risk in Chinese population

Chunze Zhang, Xichuan Li, Wenzheng Fu, Yijia Wang, Tao Wang, Wenhong Wang, Shuo Chen, Hai Qin and Xipeng Zhang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:41125-41131. https://doi.org/10.18632/oncotarget.17065

Metrics: PDF 1622 views | HTML 1943 views | ?

Abstract

Chunze Zhang1,*, Xichuan Li2,*, Wenzheng Fu1, Yijia Wang3, Tao Wang1, Wenhong Wang4, Shuo Chen1, Hai Qin1 and Xipeng Zhang1

1Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin 300121, China

2Department of Immunology, Biochemistry and Molecular Biology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Tianjin Medical University, Tianjin 300070, China

3Department of Pathology, Tianjin Union Medical Center, Tianjin 300121, China

4Department of Imaging, Tianjin Union Medical Center, Tianjin 300121, China

*These authors have contributed equally to this work

Correspondence to:

Xipeng Zhang, email: [email protected], [email protected]

Keywords: colorectal cancer, SMAD7, rs4939827, meta-analysis

Received: November 04, 2016 Accepted: March 11, 2017 Published: April 12, 2017

ABSTRACT

A genome-wide association study identified a common genetic variant rs4939827 at 18q21 in SMAD7 to be related with colorectal cancer (CRC) risk with OR=1.2 and P =7.80E-28. Until recently, several meta-analysis studies have been conducted, and reported significant association between rs4939827 and CRC risk. However none of these studies evaluated the potential association between rs4939827 and CRC risk in Chinese population. In this study, we evaluated this association by a meta-analysis using 12077 samples including 5816 CRC cases and 6261 controls. In the end, we identified the T allele of rs4939827 to be significantly related with an increase CRC risk (P=2.22E-05, OR=1.14, 95% CI 1.07-1.21) in Chinese population.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17065

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

SMAD7 rs4939827 variant contributes to colorectal cancer risk in Chinese population

Abstract